Rallybio Corporation (RLYB) Tops Q3 EPS by 56c

Rallybio Corporation (NASDAQ: RLYB) reported Q3 EPS of $0.36, $0.56 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Rallybio Corporation (RLYB) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Kaiser Aluminum names Fred Stephan as CEO, effective November 2026
• Textron Systems wins $231 million Navy contract for landing craft